David Hyde talks with Rich Sexton, chair of the Agricultural and Resource Economics Department at the University of California, Davis. Sexton explains the making of the alpaca boom and why it's now bursting.
Sean Green, seated right, is congratulated by Sean Fitzgerald, left, as Scott O'Neil looks on before Green is issued his new Washington state legal marijuana license Wednesday, March 5, 2014, in Olympia, Wash.
Ross Reynolds talks with Tim Harford, Financial Times columnist and author, about his new book "The Undercover Economist Strikes Back: How to Run – or Ruin – an Economy."
The book focuses on the work of macroeconomists and how they believe that tweaking the right dials can steer our economy away from danger. Harford also offers a macroeconomic perspective for Seattle's on-going minimum wage debate.
Residents of Seattle should know in the next few months whether low-wage workers in the city will get a raise. Mayor Ed Murray is hoping to unveil a proposal by late spring that would increase the minimum wage in the city to as much as $15 an hour.
Some of the nation's largest pharmaceutical companies have dramatically reduced payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a ProPublica analysis shows.
Eli Lilly & Co.'s payments to speakers dropped by 55 percent, from $47.9 million in 2011 to $21.6 million in 2012.
Pfizer's speaking payments fell 62 percent over the same period, from nearly $22 million to $8.3 million.